Overall, in the randomized double blind studies, patients’ mean migraine frequency changed from the baseline, of around 8.6 migraines per month, to 50 to 75 percent reduction in migraines over the course of several months.
FDA Approve First And Only IV Treatment For Migraine Prevention
